Crispr Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $8.9M | 261k | 34.03 |
| 2024-12-31 | $5.9M | 151k | 39.36 |
| 2024-09-30 | $1.1M | 24k | 46.98 |
| 2024-06-30 | $2.1M | 38k | 54.01 |
| 2024-03-31 | $6.9M | 102k | 68.16 |
| 2023-12-31 | $7.0M | 111k | 62.60 |
| 2023-09-30 | $5.1M | 112k | 45.39 |
| 2023-03-31 | $11M | 251k | 45.23 |
| 2022-12-31 | $8.3M | 205k | 40.65 |
| 2022-09-30 | $14M | 207k | 65.31 |
| 2021-12-31 | $2.3M | 31k | 75.78 |
| 2021-03-31 | $3.2M | 26k | 121.81 |
| 2020-12-31 | $31M | 204k | 153.15 |
| 2020-09-30 | $10M | 120k | 83.60 |
| 2020-06-30 | $13M | 183k | 73.45 |
| 2020-03-31 | $9.7M | 229k | 42.38 |
| 2019-12-31 | $9.1M | 149k | 60.88 |
| 2019-09-30 | $3.1M | 75k | 40.90 |
| 2019-06-30 | $3.7M | 79k | 47.18 |
| 2019-03-31 | $1.8M | 50k | 35.71 |
| 2018-12-31 | $1.3M | 46k | 28.67 |
| 2018-09-30 | $948k | 21k | 44.32 |
| 2018-06-30 | $595k | 10k | 58.79 |
| 2018-03-31 | $61k | 1.3k | 46.03 |
| 2017-12-31 | $30k | 1.3k | 23.17 |
| 2017-09-30 | $0 | 10 | 0.00 |
| 2017-03-31 | $2.0k | 100 | 20.00 |